Intercept Pharmaceuticals, Inc.
ICPT
ICPT was delisted on the 7th of November, 2023.
169 hedge funds and large institutions have $2.42B invested in Intercept Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 74 increasing their positions, 39 reducing their positions, and 49 closing their positions.
90% more repeat investments, than reductions
Existing positions increased: 74 | Existing positions reduced: 39
7% less funds holding
Funds holding: 181 → 169 (-12)
20% less first-time investments, than exits
New positions opened: 39 | Existing positions closed: 49
21% less capital invested
Capital invested by funds: $3.05B → $2.42B (-$632M)
42% less call options, than puts
Call options by funds: $56.6M | Put options by funds: $96.8M
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$49.1M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$48.6M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$48.3M |
| 4 |
AGA
Altrinsic Global Advisors
Stamford,
Connecticut
|
+$46.4M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$45.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$43.2M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$42.7M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$21.7M |
| 4 |
Bank of New York Mellon
New York
|
-$15.5M |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
-$12M |
ICPT Hedge Fund Activity: Q4 2014 in Review
169 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Intercept Pharmaceuticals, Inc. (ICPT) for Q4 2014, worth a combined $2.42B — down 21% from $3.05B a quarter earlier.
Sellers outnumbered buyers: 49 funds closed out of ICPT and 39 opened new positions — a net loss of 10 holders — while 39 trimmed existing stakes and 74 added.
The largest buyer was First Trust Advisors, adding an estimated $49.1M. The largest seller was Capital World Investors, cutting an estimated $43.2M.
- 169 institutional investors held Intercept Pharmaceuticals, Inc. (ICPT) as of Q4 2014, down from 181 in Q3 2014.
- Funds reported $2.42B of Intercept Pharmaceuticals, Inc. stock for Q4 2014, down 21% quarter-over-quarter.
- 39 funds opened new Intercept Pharmaceuticals, Inc. positions in Q4 2014 and 49 closed out, a net change of -10 holders.
- The largest Intercept Pharmaceuticals, Inc. buyer in Q4 2014 was First Trust Advisors, an estimated $49.1M added.
- The largest Intercept Pharmaceuticals, Inc. seller in Q4 2014 was Capital World Investors, an estimated $43.2M sold.
Based on aggregated 13F filings for Q4 2014.